• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Daiichi
Biotech

How Daiichi Sankyo plans to stay ahead in the ADC game

For Daiichi and its new head of R&D, the challenge is about outrunning the very ADC gold rush the company helped ignite.
Angus Liu Jun 17, 2026 6:00pm
red light green light

UniQure stock surges after FDA U-turn clears path to filing

Jun 17, 2026 9:10am
How NECs AI and oral delivery system are redefining personalized cancer therapy

How NEC's AI and oral delivery system are redefining personalized cancer therapy

Brought to you by NEC Bio
Jazzs palm tree ASCO display

Jazz, AbCellera strike TCE discovery and development deal

Jun 17, 2026 7:00am
door exit shut close end walk away

F2G, Shionogi prep regulatory push after antifungal passes ph. 3

Jun 18, 2026 12:01am
Migraine headacheepilepsy brain image

Vedana surfaces with $46M to develop migraine prevention therapies

Jun 17, 2026 9:48am
More News

Fierce Biotech Fundraising Tracker '26: Triveni Bio & more

Jun 17, 2026 9:30am
Fierce Pharma

PwC projects continued growth for rest of 2026, fueled by M&A

Jun 17, 2026 5:00am

FDA appears less prickly toward Moderna mRNA flu shot

Jun 16, 2026 2:46pm

Lilly buys 4E to beef up its non-opioid pain pipeline

Jun 16, 2026 2:34pm
See more stories
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings